http://www.advfn.com/nasdaq/rss.asp?symbol=MYL Mylan Inc. Company Newsfeed en Wed, 15 May 2013 19:00:14 EDT Wed, 15 May 2013 19:00:14 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=57595210&headline=novartis-considers-possible-bid-for-actavis http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=57595210&headline=novartis-considers-possible-bid-for-actavis <div class='newsbody'><p> A heated takeover battle has erupted around generic-drug company Actavis Inc. (ACT) as industry players seek to shore themselves up amid increasing competition and fewer new knock-off-drug opportunities. </p> <p> Valeant Pharmaceuticals International Inc. (VRX, VRX.T) and Mylan... Wed, 15 May 2013 19:00:14 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=57027802&headline=valeant-to-launch-own-version-of-generic-zovirax-in-response http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=57027802&headline=valeant-to-launch-own-version-of-generic-zovirax-in-response <div class='newsbody'><pre> By Saabira Chaudhuri </pre> <p> Valeant Pharmaceuticals International Inc. (VRX, VRX.T) said it will launch a generic version of its Zovirax ointment Thursday after Mylan Inc. (MYL) received approval to launch a similar product, a move that is expected to cut the specialty-pharmaceutical... Thu, 04 Apr 2013 09:00:14 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=56575199&headline=pfizer-get-reissued-patent-for-celebrex http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=56575199&headline=pfizer-get-reissued-patent-for-celebrex <div class='newsbody'><p> Pfizer Inc. (PFE) said the U.S. Patent &amp; Trademark Office reissued a patent on the active ingredient in Celebrex, extending the painkiller's exclusivity to 2015 from 2014. </p> <p> The pharmaceutical company said the reissue patent--covering methods of treating osteoarthritis... Tue, 05 Mar 2013 10:40:11 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=56574806&headline=pfizer-get-reissued-patent-for-celebrex-extends-exclusivity http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=56574806&headline=pfizer-get-reissued-patent-for-celebrex-extends-exclusivity <div class='newsbody'><pre> By Melodie Warner </pre> <p> Pfizer Inc. (PFE) said the U.S. Patent &amp; Trademark Office reissued a patent on the active ingredient in Celebrex, extending the painkiller's exclusivity to 2015 from 2014. </p> <p> The pharmaceutical company said the reissue patent--covering... Tue, 05 Mar 2013 10:26:13 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=56504184&headline=u-s-hot-stock-futures-hot-stocks-to-watch http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=56504184&headline=u-s-hot-stock-futures-hot-stocks-to-watch <div class='newsbody'><p> Among the companies with shares expected to actively trade in Thursday's session are Groupon Inc. (GRPN), J.C. Penney Co. (JCP) and BroadSoft Inc. (BSFT). </p> <p> Groupon posted financial results Wednesday showing the firm's core business of daily deals remains under pressure... Thu, 28 Feb 2013 09:23:15 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=56492546&headline=mylan-4th-quarter-profit-up-25-to-buy-agila-specialties-for http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=56492546&headline=mylan-4th-quarter-profit-up-25-to-buy-agila-specialties-for <div class='newsbody'><pre> By Tess Stynes and Nathalie Tadena </pre> <p> Mylan Inc.'s (MYL) fourth-quarter earnings rose 25% as the generics-drug maker reported revenue gains and unveiled plans to acquire Agila Specialties Private Ltd. for $1.6 billion in cash, strengthening its global injectables business... Wed, 27 Feb 2013 18:13:13 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=56422890&headline=ranbaxy-resumes-generic-lipitor-production-for-u-s http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=56422890&headline=ranbaxy-resumes-generic-lipitor-production-for-u-s <div class='newsbody'><p> Ranbaxy Laboratories Ltd. (500359.BY) said Friday it has resumed manufacturing generic copies of the cholesterol-lowering drug Lipitor for the U.S. market, following a production suspension late last year after tiny glass particles were found in the product. </p> <p> Ranbaxy... Fri, 22 Feb 2013 12:20:15 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=55835127&headline=pfizer-others-eye-strides-arcolabs-agila-unit-bloomberg http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=55835127&headline=pfizer-others-eye-strides-arcolabs-agila-unit-bloomberg <div class='newsbody'><p> Pfizer Inc. (PFE) is considering buying Indian drug company Strides Arcolab Ltd.'s (532531.BY) Agila Specialties unit, Bloomberg News reported Monday, citing three people with knowledge of the matter. </p> <p> Other potential suitors for the division are Mylan Inc. (MYL), Novartis... Mon, 14 Jan 2013 13:59:35 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=55552813&headline=mylan-settles-patent-dispute-over-parkinsons-treatment http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=55552813&headline=mylan-settles-patent-dispute-over-parkinsons-treatment <div class='newsbody'><p> Mylan Inc.(MYL) reached a settlement in a patent dispute with Finnish pharmaceuticals and diagnostics company Orion Corp. that will allow the U.S. drug maker to launch its generic version of a drug for Parkinson's Disease starting in April. </p> <p> Under the agreement, all... Thu, 20 Dec 2012 10:30:09 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=55552439&headline=mylan-settles-patent-dispute-over-parkinsons-treatment-recalls http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=55552439&headline=mylan-settles-patent-dispute-over-parkinsons-treatment-recalls <div class='newsbody'><pre> By Tess Stynes </pre> <p> Mylan Inc.(MYL) reached a settlement in a patent dispute with Finnish pharmaceuticals and diagnostics company Orion Corp. that will allow the U.S. drug maker to launch its generic version of a drug for Parkinson's Disease starting in April. </p> <p>... Thu, 20 Dec 2012 10:12:48 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=55111917&headline=moodys-upgrades-mylan-two-notches-to-investment-grade http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=55111917&headline=moodys-upgrades-mylan-two-notches-to-investment-grade <div class='newsbody'><pre> By Tess Stynes </pre> <p> Moody's Investors Service gave Mylan Inc. (MYL) a two-notch upgrade, raising the generic-drug maker's ratings into investment grade, on expectations the company's strong operating performance will continue. </p> <p> Moody's has Mylan at Baa3--one... Tue, 20 Nov 2012 11:16:10 EST http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=54695359&headline=mylan-ceo-eyes-acquisitions-valued-at-more-than-4-billion http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=54695359&headline=mylan-ceo-eyes-acquisitions-valued-at-more-than-4-billion <div class='newsbody'><pre> By Peter Loftus </pre> <p> Generic-drug maker Mylan Inc. (MYL) is on the prowl for acquisitions to bolster its product line and expand geographically, and would consider deals valued at "well over" $4 billion, the company's leader said Thursday. </p> <p> "I think there are... Thu, 25 Oct 2012 14:46:46 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=54129428&headline=prescriptions-for-mercks-singulair-plunge-after-loss-of-u-s http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=54129428&headline=prescriptions-for-mercks-singulair-plunge-after-loss-of-u-s <div class='newsbody'><pre> By Peter Loftus </pre> <p> Weekly prescriptions for Merck &amp; Co.'s (MRK) asthma and allergy treatment Singulair plunged nearly 90% within four weeks of the August introduction of competing generic copies, a Merck executive said Tuesday. </p> <p> "There's been a rapid decline... Tue, 11 Sep 2012 13:26:12 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=54088547&headline=mylan-agrees-to-settlement-to-sell-generic-version-of-pfizers http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=54088547&headline=mylan-agrees-to-settlement-to-sell-generic-version-of-pfizers <div class='newsbody'><pre> By Saabira Chaudhuri </pre> <p> Mylan Inc. (MYL) has agreed to a settlement with Pfizer Inc. (PFE) to resolve patent litigation related to Mylan's abbreviated new drug application for a generic version of Pfizer's overactive bladder drug. </p> <p> Mylan--the world's third-largest... Fri, 07 Sep 2012 08:31:54 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=53690654&headline=gilead-sciences-to-promote-low-cost-hiv-medicine-in-developing http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=53690654&headline=gilead-sciences-to-promote-low-cost-hiv-medicine-in-developing <div class='newsbody'><pre> By Chelsea Stevenson </pre> <p> Gilead Sciences Inc. (GILD) said it plans to partner with Mylan Inc. (MYL), Ranbaxy Laboratories Ltd. (500359.BY) and Strides Arcolab Ltd. (532531.BY) to promote access to high-quality, low-cost generic versions of Gilead's HIV medicine emtricitabine... Thu, 02 Aug 2012 10:28:23 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=53637098&headline=eu-sends-objections-on-drug-to-servier-other-manufacturers http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=53637098&headline=eu-sends-objections-on-drug-to-servier-other-manufacturers <div class='newsbody'><p> By Vanessa Mock </p> <p> BRUSSELS--European Union regulators Monday sent out a formal complaint to the French drugmaker Servier, Israel's Teva Pharmaceutical Industries Ltd. (TEVA) and four other companies for blocking the entry to market of generic perindopril, a cardiovascular... Mon, 30 Jul 2012 07:06:13 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=53531589&headline=us-judge-upholds-claims-in-pfizers-lyrica-patents http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=53531589&headline=us-judge-upholds-claims-in-pfizers-lyrica-patents <div class='newsbody'><pre> By Peter Loftus </pre> <p> A U.S. judge has upheld the validity of patents covering Pfizer Inc.'s (PFE) blockbuster pain drug Lyrica, preserving market U.S. exclusivity for one of the company's best-selling drugs through 2018. </p> <p> U.S. District Judge Gregory M. Sleet... Thu, 19 Jul 2012 17:11:25 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=53503839&headline=viiv-healthcare-partners-chai-mylan-promote-paediatric-hiv http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=53503839&headline=viiv-healthcare-partners-chai-mylan-promote-paediatric-hiv <div class='newsbody'><p> LONDON--ViiV Healthcare, a specialist HIV company established by GlaxoSmithKline (GSK.LN) and Pfizer Wednesday announced a public-private partnership with Clinton Health Access Initiative (CHAI) and Mylan Laboratories Ltd, to submit a registration file for a new dispersible... Wed, 18 Jul 2012 06:50:32 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=52876565&headline=teva-court-validates-copaxone-patents-mylan-momenta-plan-appeals http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=52876565&headline=teva-court-validates-copaxone-patents-mylan-momenta-plan-appeals <div class='newsbody'><pre> By Melodie Warner </pre> <p> Teva Pharmaceutical Industries Ltd. (TEVA) said a U.S. district court validated its patents for the multiple-sclerosis drug Copaxone and found purported generic versions by Mylan Inc. (MYL) and Momenta Pharmaceuticals Inc. (MNTA) infringe those... Mon, 25 Jun 2012 07:20:06 EDT http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=52706222&headline=mylan-teva-settle-litigation-over-generic-provigil http://www.advfn.com/nasdaq/StockNews.asp?stocknews=MYL&article=52706222&headline=mylan-teva-settle-litigation-over-generic-provigil <div class='newsbody'><pre> By Melodie Warner </pre> <p> Mylan Inc. (MYL) and Teva Pharmaceutical Industries Ltd. (TEVA) resolved their dispute over a generic version of Cephalon Inc.'s wakefulness drug Provigil, clearing the way for Mylan to launch U.S. sales of its modafinil tablets. </p> <p> Generic-drug... Fri, 08 Jun 2012 09:18:52 EDT